TAMPA, Fla.--(BUSINESS WIRE)--Demand for cannabis-infused topical remedies is rising fast across North America as more and more states and territories opt to legalize the plant. Neutra Corp. (OTCQB: NTRR) is working quickly to establish a foothold in the quickly blossoming new industry by partnering with a Canadian nutraceuticals company to offer retailers and consumers new solutions in medicinal cannabinoids.
In Colorado, the United States’ bell-weather cannabis marketplace, sales of cannabis in tourist-heavy areas are now being led by infused products and extracts as patients who are disinclined to smoke seek out new options. And business is booming: Colorado reported earlier this year that it collected more than $117 million in excise taxes since its new cannabis legislation took effect nearly two years ago.
In fact, driven in large part by infused products, the cannabis industry is now the fastest-growing in the United States.
“Cannabis-infused products represent one of the highest-margin sectors in this emerging industry,” said NTRR CEO Chris Brown. “This is a new and largely disconnected industry without traditional supply-chain networks or marketing channels, and that is creating attractive opportunities to establish ourselves as a leader in the sector. That’s why we’re working to assist our joint venture partner, Oceanview Health Services Ltd., to come up with cannabis-infused topical formulas to be licensed to producers in top cannabis markets across North America.”
NTRR signed a joint venture agreement with Vancouver-based Oceanview last week to help research cutting-edge topical creams, oils, salves, lotions and other products that have been infused with medicinal cannabis. In 2016, NTRR plans to deliver many new offerings for cannabis producers and consumers alike. The company is already marketing a line of horticultural technologies in partnership with Surface to Air Solutions, Inc., that are currently being used by cannabis growers in the U.S. and Canada.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (NASDAQ: GWPH), Cara Therapeutics Inc. (NASDAQ: CARA) and 22nd Century Group, Inc. (NASDAQ: XXII), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
